1164
Vol. 49, No. 9
d, Jϭ12.0 Hz), 6.84 (1H, d, Jϭ8.7 Hz), 7.04 (1H, dd, Jϭ18.3, 12.0 Hz), 7.12 Jϭ8.5 Hz). High-resolution MS m/z: Calcd for C11H12N2O: 188.0950.
(1H, s), 7.26 (1H, d, Jϭ8.7 Hz). High-resolution MS m/z: Calcd for Found: 188.0946.
C18H22N2O3: 314.1630. Found: 314.1630.
3,4,5,6-Tetrahydro-7-hydroxy-6-methyl-1H-azepino[5,4,3-cd]indole
(5c) from Serotonin Hydrochloride (2b·HCl) [Entry 1] Et3N (2 ml) was
3,4,5,6-Tetrahydro-7-hydroxy-6-phenyl-1H-azepino[5,4,3-cd]indole
(5f) and 1,2,3,4-Tetrahydro-6-hydroxy-1-phenyl-b-carboline (12) from
2b·HCl Benzaldehyde (0.48 ml, 4.72 mmol) was added to a solution of
added to a solution of 2b·HCl (20.9 mg, 0.10 mmol) in MeOH (2 ml) at 2b·HCl (201.4 mg, 0.95 mmol) in MeOH (5 ml) and Et3N (5 ml) at 0 °C, and
0 °C, and the mixture was refluxed for 20 h with stirring under O2 atmo- the mixture was refluxed for 20 h with stirring. The solvent was evaporated
sphere (O2 balloon). The solvent was evaporated under reduced pressure to under reduced pressure to leave an oil, which was column-chromatographed
leave an oil, which was column-chromatographed on SiO2 with CHCl3–
repeatedly on SiO2 with CHCl3–MeOH–28% aq. NH3 (46 : 3 : 0.3, 46 : 5 :
MeOH–28% aq. NH3 (46 : 5 : 0.5, then 46 : 10 : 1, v/v) to give 5c (4.0 mg, 0.5, then 46 : 10 : 1, v/v) to give 12 (3.9 mg, 2%), 5f (141.8 mg, 57%), and
20%) and unreacted 2b (10.2 mg, 59%) in the order of elution. 5c: Pale yel- unreacted 2b (25.5 mg, 15%) in the order of elution. 12: Pale yellow viscous
low oil. IR (KBr): 3400, 3300, 1579, 1417, 794 cmϪ1. 1H-NMR (CD3OD) d: oil. IR (KBr): 3400, 3290, 1625, 1593, 1454, 1201, 702 cmϪ1 1H-NMR
.
1.49 (3H, d, Jϭ6.8 Hz), 2.93—3.01 (1H, m), 3.10—3.15 (2H, m), 3.35—
3.41 (1H, m), 4.91 (1H, q, Jϭ6.8 Hz), 6.63 (1H, d, Jϭ8.6 Hz), 6.95 (1H, s), Jϭ12.5, 7.8, 5.1 Hz), 3.25 (1H, dt, Jϭ12.5, 5.1 Hz), 5.13 (1H, s), 6.60 (1H,
7.03 (1H, d, Jϭ8.6 Hz). High-resolution MS m/z: Calcd for C12H14N2O: dd, Jϭ8.5, 2.2 Hz), 6.84 (1H, d, Jϭ2.2 Hz), 7.03 (1H, d, Jϭ8.5 Hz), 7.27—
(CD3OD) d: 2.71—2.77 (1H, m), 2.82—2.88 (1H, m), 3.03 (1H, ddd,
202.1107. Found: 202.1110.
7.36 (5H, m). High-resolution MS m/z: Calcd for C17H16N2O: 264.1263.
[Entry 2] Acetaldehyde (0.016 ml, 0.29 mmol) was added to a solution of Found: 264.1259.
2b·HCl (20.5 mg, 0.10 mmol) in MeOH (2 ml) and Et3N (2 ml) at 0 °C, and
7-Acetoxy-5-acetyl-3,4,5,6-tetrahydro-6-phenyl-1H-azepino[5,4,3-
the mixture was stirred at room temperature for 4 h under O2 atmosphere (O2 cd]indole (11) from 5f Ac2O (1 ml) was added to a solution of 5f (4.7 mg,
balloon). After the same work-up and separation as described in entry 1, un-
reacted 2b (8.6 mg, 51%) was obtained.
0.02 mmol) in pyridine (2 ml) under ice cooling, and the mixture was stirred
for 3 h at room temperature. The solvent was evaporated under reduced pres-
sure to leave a solid, which was column-chromatographed on SiO2 with
CHCl3–MeOH (99 : 1, v/v) to give 11 (18.7 mg, 94%). 11: Colorless oil. IR
[Entry 3] Acetaldehyde (0.16 ml, 2.86 mmol) was added to a solution of
2b·HCl (98.1 mg, 0.46 mmol) in MeOH (4 ml) and Et3N (4 ml) at 0 °C, and
the mixture was stirred at room temperature for 24 h under O2 atmosphere (film): 3276, 1757, 1628, 1423, 1198, 750 cmϪ1 1H-NMR (DMSO-d6,
.
(O2 balloon). After the same work-up and separation as described in entry 1, 140 °C) d: 1.85 (3H, br s), 2.17 (3H, s), 2.79—4.02 (4H, m), 6.55 (1/3H, br
an unidentified product (10.1 mg) and unreacted 2b (14.9 mg, 18%) were ob- s), 6.82 (1H, d, Jϭ8.6 Hz), 6.92—6.97 (2H, m), 7.11 (1H, br s), 7.17—7.23
tained.
(3H, m), 7.31 (1H, br d, Jϭ8.6 Hz), 7.60 (2/3H, br s), 10.65 (1H, br s, disap-
[Entry 4] Acetaldehyde (0.016 ml, 0.29 mmol) was added to a solution of peared on addition of D2O). High-resolution MS m/z: Calcd for C21H20N2O3:
2b·HCl (20.5 mg, 0.10 mmol) in MeOH (2 ml) and Et3N (2 ml) at 0 °C, and
348.1474. Found: 348.1474.
the mixture was stirred at room temperature for 4 h under Ar atmosphere.
5-Hydroxy-4-(N,N-dimethylaminomethyl)tryptamine (13) from 2b·
After the same work-up and separation as described in entry 1, 5c (1.5 mg, HCl 50% Me2NH (2 ml) and HCHO (35%, 0.20 ml, 2.46 mmol) were
8%) and unreacted 2b (7.5 mg, 44%) were obtained.
added to a solution of 2b·HCl (104.5 mg, 0.49 mmol) in MeOH (2 ml) at
3,4,5,6-Tetrahydro-7-hydroxy-5,6-dimethyl-1H-azepino[5,4,3-cd]in-
0 °C. The mixture was stirred at room temperature for 4 h. After the addition
dole (5d) from Nb-Methylserotonin (2c) Method 1: Et3N (2 ml) was of H2O under ice cooling, the whole was extracted with CHCl3–MeOH
added to a solution of 2c (21.4 mg, 0.11 mmol) in MeOH (2 ml) at 0 °C, and (95 : 5, v/v). The extract was washed with brine, dried over Na2SO4, and
the mixture was refluxed for 20 h with stirring under O2 atmosphere (O2 bal- evaporated under reduced pressure to leave an oil, which was column-chro-
loon). The solvent was evaporated under reduced pressure to leave an oil, matographed on SiO2 with CHCl3–MeOH–28% aq. NH3 (46 : 3 : 0.3, v/v) to
which was column-chromatographed on SiO2, successively, with CHCl3–
give 13 (89.5 mg, 78%). 13: mp 127—128 °C (dec., unstable colorless
1
MeOH–28% aq. NH3 (46 : 5 : 0.5, then 46 : 10 : 1, v/v) to give 5d (5.6 mg, solid). IR (KBr): 3342, 1583, 1469, 1417, 1232, 991, 796 cmϪ1. H-NMR
23%) and unreacted 2c (13.4 mg, 63%) in the order of elution. 5d: Pale yel- (CD3OD) d: 2.38 (6H, s), 2.90 (2H, t, Jϭ6.6 Hz), 2.97 (2H, t, Jϭ6.6 Hz),
1
low oil. IR (KBr): 3400, 1579, 1435, 790 cmϪ1. H-NMR (CD3OD) d: 1.44 4.05 (2H, s), 6.61 (1H, d, Jϭ8.5 Hz), 6.99 (1H, s), 7.12 (1H, d, Jϭ8.5 Hz).
(3H, d, Jϭ6.8 Hz), 2.59 (3H, s), 2.97—3.04 (2H, m), 3.19—3.27 (1H, m), High-resolution MS m/z: Calcd for C13H19N3O: 233.1528. Found: 233.1525.
3.60—3.68 (1H, m), 4.73 (1H, q, Jϭ6.8 Hz), 6.65 (1H, d, Jϭ8.6 Hz), 6.95
3,4,5,6-Tetrahydro-7-hydroxy-1H-azepino[5,4,3-cd]indole (5e) from 13
(1H, s), 7.03 (1H, d, Jϭ8.6 Hz). High-resolution MS m/z: Calcd for A solution of 13 (10.5 mg, 0.05 mmol) in MeOH (2 ml) was refluxed for 9 h
C13H16N2O: 216.1262. Found: 216.1266.
with stirring. The solvent was evaporated under reduced pressure to leave an
oil, which was column-chromatographed on SiO2 with CHCl3–MeOH–28%
aq. NH3 (46 : 3 : 0.3, v/v) to give 5e (3.0 mg, 35%).
Method 2: Acetaldehyde (0.018 ml, 0.32 mmol) was added to a solution of
2c (20.3 mg, 0.11 mmol) in MeOH (2 ml) and Et3N (2 ml) at 0 °C, and the
mixture was stirred at room temperature for 4 h under O2 atmosphere (O2
5-Methoxy-Nb-methyltryptamine6) (16) from 5-Methoxy-Nb-methoxy-
balloon). The solvent was evaporated under reduced pressure to leave an oil, carbonyltryptamine9) (17) LiAlH4 (184.7 mg, 4.87 mmol) was added to a
which was column-chromatographed on SiO2 with CHCl3–MeOH–28% aq. solution of 175) (120.6 mg, 0.49 mmol) in anhydrous THF (20 ml) at 0 °C,
NH3 (46 : 5 : 0.5, v/v) to give 5d (18.5 mg, 80%).
and the mixture was refluxed for 1 h with stirring. After the addition of
3,4,5,6-Tetrahydro-7-hydroxy- (5e), -6-Phenyl-1H-azepino[5,4,3-cd]in- MeOH and saturated Rochelle salt under ice cooling, the whole was ex-
dole (5f), and 1,2,3,4-Tetrahydro-6-hydroxy-b-carboline (10) from 2b· tracted with CHCl3. The extract was washed with brine, dried over Na2SO4,
HCl N,N-Dimethylbenzylamine (2 ml) was added to a solution of 2b·HCl and evaporated under reduced pressure to leave an oil, which was column-
(20.5 mg, 0.10 mmol) in MeOH (2 ml) at 0 °C, and the mixture was refluxed
chromatographed on SiO2 with CHCl3–MeOH–28% aq. NH3 (46 : 3 : 0.3,
for 6 h with stirring under O2 atmosphere (O2 balloon). The solvent was v/v) to give 166a) (93.0 mg, 94%).
evaporated under reduced pressure to leave an oil, which was column-chro-
1,2,3,4-Tetrahydro-6-methoxy-1,2-dimethyl-b-carboline (18) from 16
matographed on SiO2 successively with CHCl3–MeOH–28% aq. NH3 A solution of 16 (49.4 mg, 0.24 mmol) in MeOH (3.5 ml) was made acidic
(46 : 3 : 0.3, then 46 : 5 : 0.5, v/v) to give 5f (2.3 mg, 9%), 5e (2.5 mg, 14%), (pH 5.0) by adding 1% HCl in MeOH (v/v). Acetaldehyde (0.67 ml,
10 (1.0 mg, 6%), and unreacted 2b (4.9 mg, 29%) in the order of elution. 5e: 12.0 mmol) in MeOH (0.5 ml) was added to the solution at 0 °C, and the
Pale beige viscous oil. IR (KBr): 3305, 1581, 1433, 795 cmϪ1 1H-NMR mixture was refluxed for 20 h with stirring. The solvent was evaporated
.
(CD3OD) d: 3.08 (2H, t, Jϭ5.4 Hz), 3.20 (2H, t, Jϭ5.4 Hz), 4.31 (2H, s), under reduced pressure to leave a solid, which was subjected to p-TLC on
6.65 (1H, d, Jϭ8.5 Hz), 6.99 (1H, s), 7.05 (1H, d, Jϭ8.5 Hz). High-resolu- SiO2, developed twice with CHCl3–MeOH–28% aq. NH3 (46 : 3 : 0.3, v/v).
tion MS m/z: Calcd for C11H12N2O: 188.0950. Found: 188.0949. 5f: mp
Extraction of the band having an Rf value of 0.43—0.27 with CHCl3–
122.5—124.0 °C (colorless prisms, recrystallized from CHCl3–MeOH). IR MeOH–28% aq. NH3 (46 : 3 : 0.3, v/v) gave 18 (45.9 mg, 82%). 18: mp
1
(KBr): 3290, 1577, 1425, 1298, 1242, 1011, 796, 756, 704 cmϪ1. H-NMR 155—157 °C (colorless powder, recrystallized from CHCl3–hexane). IR
1
(CD3OD) d: 2.79 (1H, ddd, Jϭ13.4, 4.6, 3.7 Hz), 2.87 (1H, ddd, Jϭ13.4, (KBr): 1629, 1602, 1489, 1217, 1157, 820 cmϪ1. H-NMR (CDCl3) d: 1.44
11.0, 4.2 Hz), 2.94—3.04 (2H, m), 5.92 (1H, s), 6.63 (1H, d, Jϭ8.6 Hz), (3H, d, Jϭ6.6 Hz), 2.51 (3H, s), 2.70—2.75 (2H, m), 2.78—2.85 (1H, m),
6.98 (1H, s), 7.03 (2H, br d, Jϭ7.3 Hz), 7.13 (1H, d, Jϭ8.6 Hz), 7.11—7.20 3.11—3.15 (1H, m), 3.56 (1H, q, Jϭ6.6 Hz), 3.85 (3H, s), 6.79 (1H, dd,
(3H, m). MS m/z: 264 (Mϩ). Anal. Calcd for C17H16N2O·MeOH: C, 72.95; Jϭ8.8, 2.4 Hz), 6.94 (1H, d, Jϭ2.4 Hz), 7.19 (1H, d, Jϭ8.8 Hz), 7.56 (1H,
H, 6.80; N, 9.45. Found: C, 73.19; H, 6.78; N, 9.40. 10: mp 285 °C (dec., br s, disappeared on addition of D2O). MS m/z: 230 (Mϩ). Anal. Calcd for
colorless powder). IR (KBr): 3398, 3265, 1589, 1565, 1454, 1200 cmϪ1. 1H- C14H18N2O·1/4H2O: C, 71.61; H, 7.94; N, 11.93. Found: C, 71.37; H, 7.75;
NMR (CD3OD) d: 2.71 (2H, t, Jϭ5.9 Hz), 3.13 (2H, t, Jϭ5.9 Hz), 3.96 (2H, N, 11.88.
s), 6.60 (1H, dd, Jϭ8.5, 2.3 Hz), 6.77 (1H, d, Jϭ2.3 Hz), 7.08 (1H, d,
Reaction of Nb-Methyltryptamine (20) with Et3N Et3N (2 ml) was